Patent ID: 8507528
Filing Date: 2013-08-13
Classification: A61P,C07D

Abstract:
1. A compound which is selected from the group consisting of N,2-dimethyl-N-{[1-(2-phenylethyl)piperidin-4-yl]methyl}-2H-indazole-3-carboxamide hydrochloride hemihydrate; N-({1-[2-(4-hydroxyphenyl)ethyl]piperidin-4-yl}methyl)-5-methoxy-2-methyl-2H-indazole-3-carboxamide; N-({1[2-(4-fluorophenyl)ethyl]piperidin-4-yl}methyl)-2-(2-methoxyethyl)-2-H-indazole-3-carboxamide hydrochloride; N-({1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl}methyl)-2-methyl-2H-indazole-3-carboxamide hydrochloride; 2-(2,4-difluorophenyl)-N-({1-[(2-methyl-2H-indazole-3-yl)carbonyl]piperidin-4-yl}methyl)ethanamine hydrochloride; and 2-(4-fluorophenyl)-N-({1-[(2-methyl-2H-indazol-3-yl)carbonyl)piperidin-4-yl}methyl]ethanamine hydrochloride, or a pharmaceutically acceptable salt of said compound.